IRIS Accounts Production v23.4.0.336 07665801 director 1.1.23 31.12.23 31.12.23 false true false false true false Ordinary 10.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh076658012022-12-31076658012023-12-31076658012023-01-012023-12-31076658012021-12-31076658012022-01-012022-12-31076658012022-12-3107665801ns15:EnglandWales2023-01-012023-12-3107665801ns14:PoundSterling2023-01-012023-12-3107665801ns10:Director12023-01-012023-12-3107665801ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107665801ns10:SmallEntities2023-01-012023-12-3107665801ns10:AuditExemptWithAccountantsReport2023-01-012023-12-3107665801ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107665801ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3107665801ns10:FullAccounts2023-01-012023-12-3107665801ns10:OrdinaryShareClass12023-01-012023-12-3107665801ns10:RegisteredOffice2023-01-012023-12-3107665801ns5:CurrentFinancialInstruments2023-12-3107665801ns5:CurrentFinancialInstruments2022-12-3107665801ns5:ShareCapital2023-12-3107665801ns5:ShareCapital2022-12-3107665801ns5:RetainedEarningsAccumulatedLosses2023-12-3107665801ns5:RetainedEarningsAccumulatedLosses2022-12-3107665801ns5:PlantMachinery2023-01-012023-12-3107665801ns5:PlantMachinery2022-12-3107665801ns5:PlantMachinery2023-12-3107665801ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3107665801ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3107665801ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 07665801 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

Med-Eq (Europe) Limited

Med-Eq (Europe) Limited (Registered number: 07665801)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 4


Med-Eq (Europe) Limited

Company Information
for the Year Ended 31 December 2023







DIRECTOR: Mr N Avgerinos





REGISTERED OFFICE: Milton House
Gatehouse Road
Aylesbury
Buckinghamshire
HP19 8EA





REGISTERED NUMBER: 07665801 (England and Wales)





ACCOUNTANTS: Haines Watts
Chartered Accountants
Milton House
Gatehouse Road
Aylesbury
Buckinghamshire
HP19 8EA

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Med-Eq (Europe) Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Med-Eq (Europe) Limited for the year ended 31 December 2023 which comprise the Statement of Income and Retained Earnings, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Med-Eq (Europe) Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Med-Eq (Europe) Limited and state those matters that we have agreed to state to the director of Med-Eq (Europe) Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Med-Eq (Europe) Limited and its director for our work or for this report.

It is your duty to ensure that Med-Eq (Europe) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Med-Eq (Europe) Limited. You consider that Med-Eq (Europe) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Med-Eq (Europe) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Haines Watts
Chartered Accountants
Milton House
Gatehouse Road
Aylesbury
Buckinghamshire
HP19 8EA


28 March 2024

Med-Eq (Europe) Limited (Registered number: 07665801)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £   
CURRENT ASSETS
Stocks 116,273 107,842
Debtors 5 245,060 179,889
Investments 6 40,440 20,799
Cash at bank 232,972 186,328
634,745 494,858
CREDITORS
Amounts falling due within one year 7 96,404 94,784
NET CURRENT ASSETS 538,341 400,074
TOTAL ASSETS LESS CURRENT LIABILITIES 538,341 400,074

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 537,341 399,074
SHAREHOLDERS' FUNDS 538,341 400,074

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 March 2024 and were signed by:





Mr N Avgerinos - Director


Med-Eq (Europe) Limited (Registered number: 07665801)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Med-Eq (Europe) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Med-Eq (Europe) Limited (Registered number: 07665801)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023
and 31 December 2023 17,500
DEPRECIATION
At 1 January 2023
and 31 December 2023 17,500
NET BOOK VALUE
At 31 December 2023 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 181,544 130,158
Amounts owed by group undertakings 27,336 120
Other debtors 36,180 49,611
245,060 179,889

6. CURRENT ASSET INVESTMENTS
31.12.23 31.12.22
£    £   
Unlisted investments 40,440 20,799

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 52,969 47,096
Taxation and social security 42,535 36,389
Other creditors 900 11,299
96,404 94,784

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
100 Ordinary £10 1,000 1,000